TrialAnnals of the rheumatic diseases2023

Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus.

Eric F Morand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.